Boyle P J, Nagy R J, O'Connor A M, Kempers S F, Yeo R A, Qualls C
Department of Medicine, University of New Mexico, Albuquerque 87131.
Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9352-6. doi: 10.1073/pnas.91.20.9352.
Brain glucose metabolism is impaired during hypoglycemia, but, if sustained, brain metabolism reverts to normal in animal models--data in man are lacking. We tested the hypothesis that adaptations occur to allow maintenance of normal rates of brain glucose uptake (BGU) following recurrent hypoglycemia in man. Twelve normal humans were studied over 4 days. On the initial day, arterial plasma glucose concentrations were decreased from 4.72 to 2.50 mmol/liter in five 0.56 mmol/liter steps. Cerebral blood flow, brain arteriovenous glucose difference, BGU, and cognitive function were quantitated at each step. BGU was initially impaired at the 3.61 mmol/liter glucose step (P = 0.04) and was antedated by increments in epinephrine that began at 4.16 mmol/liter (P = 0.03). The onset of hypoglycemic symptoms occurred during the 3.61 mmol/liter glucose step (P = 0.02), whereas tests of cognitive function generally deteriorated at the 3.05 mmol/liter step (P < 0.05). During the next 56 hr, mean glucose concentrations were kept at 2.9 +/- 0.1 mmol/liter and reached normal only during meals. The stepped clamp protocol was repeated beginning at 4.16 mmol/liter on the last day. No decrement in BGU was observed at any step; cognitive function was preserved until significantly lower glucose concentrations on the final day relative to the first (P = 0.04). Subjects remained asymptomatic of hypoglycemia until they reached a glucose concentration of 2.50 mmol/liter (P < 0.001 vs. day 1), while initial increments in all counterregulatory hormones were forestalled to lower glucose steps than on day 1. Therefore, adaptations occur that allow normal BGU and cerebral function to be maintained during recurrent systemic hypoglycemia. Counterregulatory events that should result in symptoms of hypoglycemia and increments in endogenous glucose production are prevented until extremely subnormal glucose concentrations.
低血糖期间脑葡萄糖代谢受损,但在动物模型中,如果持续存在,脑代谢会恢复正常——人体数据尚缺。我们检验了这样一个假设,即人体反复发生低血糖后会出现适应性变化,以维持正常的脑葡萄糖摄取率(BGU)。对12名正常人进行了为期4天的研究。在第一天,动脉血浆葡萄糖浓度分五个0.56 mmol/L的梯度从4.72 mmol/L降至2.50 mmol/L。在每个梯度下对脑血流量、脑动静脉葡萄糖差值、BGU和认知功能进行定量测定。在葡萄糖浓度为3.61 mmol/L时,BGU最初受损(P = 0.04),在葡萄糖浓度为4.16 mmol/L时肾上腺素开始升高,此变化先于BGU受损(P = 0.03)。低血糖症状在葡萄糖浓度为3.61 mmol/L时出现(P = 0.02),而认知功能测试在葡萄糖浓度为3.05 mmol/L时普遍恶化(P < 0.05)。在接下来的56小时内,平均葡萄糖浓度维持在2.9±0.1 mmol/L,仅在进餐时恢复正常。在最后一天,从4.16 mmol/L开始重复阶梯式钳夹方案。在任何梯度下均未观察到BGU降低;与第一天相比,直到最后一天葡萄糖浓度显著降低时认知功能才受到影响(P = 0.04)。受试者在血糖浓度降至2.50 mmol/L之前一直没有低血糖症状(与第一天相比,P < 0.001),同时所有对抗调节激素的初始升高被延迟到比第一天更低的葡萄糖梯度。因此,人体反复发生全身性低血糖期间会出现适应性变化,从而维持正常的BGU和脑功能。对抗调节事件本应导致低血糖症状和内源性葡萄糖生成增加,但直到葡萄糖浓度极低时才会发生。